Biotechnocentre Letter issue 73, 2020 October

Metabolomic Nuclear Magnetic Resonance Studies at Presymptomatic and Symptomatic Stages of Huntington’s Disease on a Drosophila Model

NMR studies show 16 metabolites discriminate symptomatic from presymptomatic stages in a Drosophila model of Huntington's disease. Potential biomarkers of the human disease?

Targeting the LINGO-1 receptor and its hetero-complexes: new therapeutic perspectives for the treatment of demyelinating and neurodegenerative diseases

CBM researchers in collaboration with INSERM U1195 (Kremlin-Bicêtre) have shown that the LINGO-1 receptor can form homo- and hetero-complexes with its homologs LINGO-2, LINGO-3 and LINGO-4 in the brain thus opening the way to new strategies to modulate their activity.

Enter in CBM labs !

Discover some experiences

Pure and stable white light

Researchers from CBM and the University of Michigan used a lanthanide, dysprosium, to generate pure white light with no variation in hue.

Does your ten-year-old code still run?

Scientists increasingly rely on software, but software is fragile. How long can we expect our software to remain usable? Only practice can tell.

Impact of pesticides on health through diet

Publication of an article by Jean-Marc Bonmatin and his collaborators from the Task Force on Systemic Pesticides on the impact of pesticides on health through food, and on alternative agronomic solutions

Biotechnocentre Letter - July 2020

Cancellation of Biotechnocentre events in 2020

In favor of biodiversity

Solutions for the conservation and restoration of biodiversity

Creation of a predictive model of metabolic changes characteristic of neurodegenerative diseases

Researchers have created a predictive model based on the detection of changes in metabolite concentration resolved by ¹H high-resolution MAS NMR

Achille Le Bel Grand Prize awarded to Eva Jakab Toth

The Achille Le Bel Grand Prize, awarded by the Société Chimique de France, rewards internationally recognized works.